The potential impact of pneumococcal conjugate vaccine in Africa: Considerations and early lessons learned from the South African experience

Human Vaccines & Immunotherapeutics
Shabir A Madhi, Marta C Nunes

Abstract

The introduction of pneumococcal conjugate vaccine (PCV) into the South African public immunization program since 2009 adopted a novel vaccination schedule of 3 doses at 6, 14 and 40 weeks of age. Over the past 5 y it has been shown that infant PCV immunization in South Africa is effective in reducing the burden of invasive pneumococcal disease (IPD) among HIV-infected and HIV-uninfected children. Furthermore, indirect protection of unvaccinated age-groups (including high risk groups such as HIV-infected adults) against IPD was demonstrated despite the absence of any substantial catch-up campaign of older children. This indirect effect against IPD is corroborated by the temporal reduction in vaccine-serotype colonization among age-groups targeted for PCV immunization as well as unvaccinated HIV-infected and HIV-uninfected adults, which was evident within 2 y of PCV introduction into the immunization program. Vaccine effectiveness has also been demonstrated in children against presumed bacterial pneumonia. The evaluation of the impact of PCV in South Africa, however, remains incomplete. The knowledge gaps remaining include the evaluation of PCV on the incidence of all-cause pneumonia hospitalization among vaccinated and unvaccin...Continue Reading

References

Jul 27, 1996·Lancet·S K ObaroB M Greenwood
Sep 9, 1999·The Journal of Infectious Diseases·N MbelleK P Klugman
Oct 3, 2003·The New England Journal of Medicine·Keith P KlugmanUNKNOWN Vaccine Trialists Group
Jul 13, 2004·Nature Medicine·Shabir A MadhiUNKNOWN Vaccine Trialist Group
Apr 22, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Shabir A MadhiKeith P Klugman
Jan 6, 2006·The Pediatric Infectious Disease Journal·Shabir A MadhiKeith P Klugman
Mar 29, 2006·The Pediatric Infectious Disease Journal·David GoldblattElizabeth Miller
Apr 13, 2006·JAMA : the Journal of the American Medical Association·Katherine A PoehlingWilliam Schaffner
Jul 20, 2006·JAMA : the Journal of the American Medical Association·Philimon GonaGeorge R Seage
Nov 30, 2007·Tropical Medicine & International Health : TM & IH·Godwin EnwereFelicity Cutts
Sep 15, 2009·Lancet·Katherine L O'BrienUNKNOWN Hib and Pneumococcal Global Burden of Disease Study Team
Jun 30, 2010·The Journal of Infectious Diseases·Shabir A MadhiUNKNOWN Comprehensive International Program of Research on AIDS 4 Study Team
Aug 10, 2010·Vaccine·Linda R OjoRana Hajjeh
Mar 17, 2011·The Pediatric Infectious Disease Journal·María Catalina PírezAlicia Montano
Aug 23, 2011·The Pediatric Infectious Disease Journal·Warunee PunpanichShabir A Madhi
May 25, 2012·Vaccine·UNKNOWN WHO Publication
Feb 12, 2013·Bulletin of the World Health Organization·Peter BarronAmeena Goga
Apr 16, 2013·Lancet·Christa L Fischer WalkerRobert E Black
May 1, 2013·Emerging Infectious Diseases·Eliane Terezinha AfonsoAna Lucia Andrade
Sep 10, 2013·American Journal of Epidemiology·Daniel M WeinbergerDaniel R Feikin
Dec 18, 2013·The Pediatric Infectious Disease Journal·Jennifer D LooCynthia G Whitney

❮ Previous
Next ❯

Citations

Apr 15, 2017·Expert Review of Vaccines·Robert CohenCorinne Levy
Sep 11, 2019·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Catherine Boni-CisseMartin Antonio
Sep 11, 2019·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Enyonam TsolenyanuMartin Antonio
Sep 11, 2019·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Mouhamadou A SonkoMartin Antonio
Jul 16, 2020·Journal of Community Psychology·Jacqueline Akhurst
Sep 11, 2019·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Bakary SannehMartin Antonio
Dec 4, 2020·Expert Review of Vaccines·Deus ThindwaStefan Flasche
Jun 21, 2020·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·John Njuma LibweaArto A Palmu

❮ Previous
Next ❯

Clinical Trials Mentioned

NCT00099658

Software Mentioned

GAVI

Related Concepts

Related Feeds

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.